Cargando…
Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug
[Image: see text] Expression of β-lactamase is the single most prevalent determinant of antibiotic resistance, rendering bacteria resistant to β-lactam antibiotics. In this article, we describe the development of an antibiotic prodrug that combines ciprofloxacin with a β-lactamase-cleavable motif. T...
Autores principales: | Evans, Lindsay E., Krishna, Aishwarya, Ma, Yajing, Webb, Thomas E., Marshall, Dominic C., Tooke, Catherine L., Spencer, James, Clarke, Thomas B., Armstrong, Alan, Edwards, Andrew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511942/ https://www.ncbi.nlm.nih.gov/pubmed/31009558 http://dx.doi.org/10.1021/acs.jmedchem.8b01923 |
Ejemplares similares
-
Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
por: van Haren, Matthijs J., et al.
Publicado: (2021) -
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
por: Tooke, Catherine L., et al.
Publicado: (2019) -
Antibacterial Prodrugs to Overcome Bacterial Resistance
por: Jubeh, Buthaina, et al.
Publicado: (2020) -
Studies on the Reactions of Biapenem with VIM Metallo β-Lactamases and the Serine β-Lactamase KPC-2
por: Lucic, Anka, et al.
Publicado: (2022) -
The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021)